| | Per 5- Year Note | | | 5-Year Notes Total | | | Per 7- Year Note | | | 7-Year Notes Total | | | Per 10- Year Note | | | 10-Year Notes Total | | | Per 30- Year Note | | | 30-Year Notes Total | |
Public offering price(1) | | | 99.889% | | | $998,890,000 | | | 99.852% | | | $748,890,000 | | | 99.953% | | | $1,249,412,500 | | | 99.855% | | | $1,497,825,000 |
Underwriting discount | | | 0.350% | | | $3,500,000 | | | 0.400% | | | $3,000,000 | | | 0.450% | | | $5,625,000 | | | 0.875% | | | $13,125,000 |
Proceeds, before expenses, to The Cigna Group(1) | | | 99.539% | | | $995,390,000 | | | 99.452% | | | $745,890,000 | | | 99.503% | | | $1,243,787,500 | | | 98.980% | | | $1,484,700,000 |
(1) | Plus accrued interest, if any, from February 13, 2024 to the date of delivery. |